Fluorescent hiPSC-Derived MYH6-mScarlet Cardiomyocytes for Real-Time Tracking, Imaging, and Cardiotoxicity Assays

To further expand hiPSC-derived cardiomyocytes’ (CMs) potential as a research tool and bridge the translational gap, investigators have generated a cardiac-specific hiPSC reporter line that differentiated into fluorescent CMs using CRISPR-Cas9 genome editing technology.